SHLP-2 Research for Parkinson's Disease
An evidence-based overview of research examining SHLP-2 in the context of parkinson's disease. This page synthesizes findings from peer-reviewed literature.
Research Summary
Observational human genetic studies found that a naturally occurring SHLP-2 variant (K4R) is associated with significantly reduced Parkinson's disease risk. Mechanistic studies showed SHLP-2 binds and stabilizes mitochondrial complex 1, which is dysfunctional in PD. Animal models demonstrated protection against PD-inducing toxins. No therapeutic trials in humans.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Parkinson's Disease
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. SHLP-2 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.